Michael M. Derkacz

Directeur Général chez BRAEBURN INC.

56 ans

Health Technology

Consumer Services

Commercial Services

Postes actifs de Michael M. Derkacz

Sociétés	Poste	Début	Fin
BRAEBURN INC.	Directeur/Membre du Conseil	05/06/2017	-
	Directeur Général	05/06/2017	-
	President	05/06/2017	-

Sociétés	Poste	Début	Fin
AUSPEX PHARMACEUTICALS INC	Corporate Officer/Principal	05/05/2015	-
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Corporate Officer/Principal	-	-
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01/01/2011	-

The University of Texas at Austin

Undergraduate Degree

Internationale

Etats-Unis	5
Israël	2

Opérationnelle

Corporate Officer/Principal	3
Undergraduate Degree	1
Director/Board Member	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Health Technology

Entreprise privées	3
Auspex Pharmaceuticals, Inc. Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA.	Health Technology
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Health Technology
Braeburn, Inc. Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ.	Commercial Services